Show simple item record

dc.contributor.authorPe'er, D.
dc.contributor.authorOgawa, S.
dc.contributor.authorElhanani, O.
dc.contributor.authorKeren, L.
dc.contributor.authorOliver, T. G
dc.contributor.authorWedge, David C
dc.date.accessioned2021-09-07T13:16:24Z
dc.date.available2021-09-07T13:16:24Z
dc.date.issued2021en
dc.identifier.citationPe’er D, Ogawa S, Elhanani O, Keren L, Oliver TG, Wedge D. Tumor heterogeneity. Cancer Cell. 2021 Aug;39(8):1015–7.en
dc.identifier.pmid34375606en
dc.identifier.doi10.1016/j.ccell.2021.07.009en
dc.identifier.urihttp://hdl.handle.net/10541/624566
dc.description.abstractTumor heterogeneity was traditionally considered in the genetic terms, but it has now been broadened into many more facets. These facets represent a challenge in our understanding of cancer etiology but also provide opportunity for us to understand prognosis and therapy response.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.ccell.2021.07.009en
dc.titleTumor heterogeneityen
dc.typeOtheren
dc.contributor.departmentNot availableen
dc.identifier.journalCancer Cellen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record